OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
August 12, 2022
Published in Optometry & Visual Sciences, the findings are based on an independent survey featuring feedback from over 500 US eye care professionals.
Studies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.
August 11, 2022
IBI324 is a potential first-in-class ophthalmic recombinant human anti-VEGF-A and anti-Ang-2 bispecific antibody.
August 10, 2022
Optometry Times' editor Kassi Jackson speaks with Lauretta Justin, OD, founder of Optometry Divas, and Lisa Hornick, OD, recipient of Optometry Divas' Thought Leader of the Year 2022 award.
August 08, 2022
Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.
August 03, 2022
Ranibizumab-eqrn will offer greater treatment access and choice for patients, payors, and providers in the US.
Expert advice offers key practice management tips for making presbyopia drops an integrated part of a clinical armamentarium.
August 02, 2022
COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023.
August 01, 2022
The organization has hired Maggie Cline as the new executive director of Utah.
Korean investigators have found intermittent fasting may actually lead to a lower risk of developing AMD in the elderly population.
Report: ortho-K expected to surge over next 2 years
Impact of vision impairment on children’s mental health
First patient dosed in phase 1 study of IBI324 for DME
Study: Neurolenses significantly impact reading speed